Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chromium for Steroid-Induced Hyperglycemia in Diabetic SI Joint Injection
NCT06709313Phase 4Active, not recruiting
- Sponsor
- Fayoum University
- Start
- Jun 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of chromium in hyperglycemia, sponsored by Fayoum University. Started Jun 2024; status: active, not recruiting.
02
Drugs
chromium
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT06709313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06709313.